Vascular Targeting of Adipose Tissue

  • Ahmad Salameh
  • Mikhail G. KoloninEmail author
Part of the Energy Balance and Cancer book series (EBAC, volume 7)


Obesity is a rapidly increasing worldwide threat to health due to its ­association with cardiovascular disease, diabetes, cancer, and a number of other medical conditions. Considerable efforts are underway to develop drugs for obesity prevention and treatment. Like tumors, white adipose tissue (WAT) overgrowing in obesity depends on functional blood vessels for its expansion and maintenance. Recent findings indicate the apparent vasculogenic role of WAT-derived cells recruited by tumors. Based on these notions, endothelial and perivascular cell populations in WAT have been considered as potential therapy targets in the context of obesity and cancer. In this chapter, we discuss studies aimed at inactivation of WAT vasculature and evaluate it as a prospective approach to treating obesity and its potential implications for cancer and other diseases.


Vascular Endothelial Growth Factor Adipose Tissue Brown Adipose Tissue White Adipose Tissue Subcutaneous White Adipose Tissue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kras KM et al (1999) Adipocyte development is dependent upon stem cell recruitment and proliferation of preadipocytes. Obes Res 7(5):491–497PubMedGoogle Scholar
  2. 2.
    Sun K, Kusminski CM, Scherer PE (2011) Adipose tissue remodeling and obesity. J Clin Invest 121(6):2094–2101PubMedGoogle Scholar
  3. 3.
    Ducharme NA, Bickel PE (2008) Lipid droplets in lipogenesis and lipolysis. Endocrinology 149(3):942–949PubMedGoogle Scholar
  4. 4.
    Rosen ED, Spiegelman BM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444(7121):847–853PubMedGoogle Scholar
  5. 5.
    Wisse BE, Kim F, Schwartz MW (2007) Physiology. An integrative view of obesity. Science 318(5852):928–929PubMedGoogle Scholar
  6. 6.
    Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169(5):1505–1522PubMedGoogle Scholar
  7. 7.
    Flegal KM et al (2007) Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298(17):2028–2037PubMedGoogle Scholar
  8. 8.
    Sirin O, Kolonin MG (2012) Treatment of obesity as a potential complementary approach to cancer therapy. Drug Discov Today, Online ahead of printGoogle Scholar
  9. 9.
    Kant P, Hull MA (2011) Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol 8(4):224–238PubMedGoogle Scholar
  10. 10.
    Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316PubMedGoogle Scholar
  11. 11.
    Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591PubMedGoogle Scholar
  12. 12.
    Eheman C et al (2012) Annual report to the nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 118(9):2338–2366PubMedGoogle Scholar
  13. 13.
    Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8(5):395–408PubMedGoogle Scholar
  14. 14.
    Hursting SD et al (2007) The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res 67(6):2391–2393PubMedGoogle Scholar
  15. 15.
    Zhang Y et al (2012) Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment. Cancer Res 72(20):5198–5208PubMedGoogle Scholar
  16. 16.
    Pierce J, Natarajan L, Caan BJ (2007) Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women’s Healthy Eating and Living (WHEL) randomized trial. JAMA 298(3):289–298PubMedGoogle Scholar
  17. 17.
    Ailhaud G, Grimaldi P, Negrel R (1992) Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 12:207–233PubMedGoogle Scholar
  18. 18.
    Klein J et al (2006) Adipose tissue as source and target for novel therapies. Trends Endocrinol Metab 17(1):26–32PubMedGoogle Scholar
  19. 19.
    Lafontan M (2005) Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol 45:119–146PubMedGoogle Scholar
  20. 20.
    Klaus S (2004) Adipose tissue as a regulator of energy balance. Curr Drug Targets 5(3):241–250PubMedGoogle Scholar
  21. 21.
    Tam CS, Lecoultre V, Ravussin E (2012) Brown adipose tissue: mechanisms and potential therapeutic targets. Circulation 125(22):2782–2791PubMedGoogle Scholar
  22. 22.
    Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84(1):277–359PubMedGoogle Scholar
  23. 23.
    Nedergaard J, Bengtsson T, Cannon B (2007) Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293(2):444–452Google Scholar
  24. 24.
    Park J, Euhus DM, Scherer PE (2011) Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev 32(4):550–570PubMedGoogle Scholar
  25. 25.
    Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6):2548–2556PubMedGoogle Scholar
  26. 26.
    Paz-Filho G et al (2011) Associations between adipokines and obesity-related cancer. Front Biosci 16:1634–1650PubMedGoogle Scholar
  27. 27.
    Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92(3):347–355PubMedGoogle Scholar
  28. 28.
    Khandekar MJ, Cohen P, Spiegelman BM (2011) Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11(12):886–895PubMedGoogle Scholar
  29. 29.
    Hausman DB et al (2001) The biology of white adipocyte proliferation. Obes Rev 2(4):239–254PubMedGoogle Scholar
  30. 30.
    Nishimura S et al (2007) Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56(6):1517–1526PubMedGoogle Scholar
  31. 31.
    Daquinag AC, Zhang Y, Kolonin MG (2011) Vascular targeting of adipose tissue as an anti-obesity approach. Trends Pharmacol Sci 32(5):300–307PubMedGoogle Scholar
  32. 32.
    Cao Y (2007) Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117(9):2362–2368PubMedGoogle Scholar
  33. 33.
    Traktuev D et al (2008) A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 102(1):77–85PubMedGoogle Scholar
  34. 34.
    Tang W et al (2008) White fat progenitor cells reside in the adipose vasculature. Science 322(5901):583–586PubMedGoogle Scholar
  35. 35.
    Spalding KL et al (2008) Dynamics of fat cell turnover in humans. Nature 453(7196):783–787PubMedGoogle Scholar
  36. 36.
    Gimble JM, Katz AJ, Bunnell BA (2007) Adipose-derived stem cells for regenerative ­medicine. Circ Res 100(9):1249–1260PubMedGoogle Scholar
  37. 37.
    Daquinag AC et al (2011) An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. Cell Stem Cell 9(1):74–86PubMedGoogle Scholar
  38. 38.
    Lee NK et al (2011) Identification of a novel peptide ligand targeting visceral adipose tissue via transdermal route by in vivo phage display. J Drug Target 19(9):805–813PubMedGoogle Scholar
  39. 39.
    Folkman J (2006) Angiogenesis. Annu Rev Med 57:1–18PubMedGoogle Scholar
  40. 40.
    Cao Y (2010) Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 9(2):107–115PubMedGoogle Scholar
  41. 41.
    Bertolini F et al (2006) The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 6(11):835–845PubMedGoogle Scholar
  42. 42.
    Tilki D et al (2009) Emerging biology of vascular wall progenitor cells in health and disease. Trends Mol Med 15(11):501–509PubMedGoogle Scholar
  43. 43.
    Wels J et al (2008) Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev 22(5):559–574PubMedGoogle Scholar
  44. 44.
    Gupta RK et al (2012) Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab 15(2):230–239PubMedGoogle Scholar
  45. 45.
    Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, ­concepts, and assays. Cell Stem Cell 2(4):313–319PubMedGoogle Scholar
  46. 46.
    Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9(1):11–15PubMedGoogle Scholar
  47. 47.
    Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276(5309):71–74PubMedGoogle Scholar
  48. 48.
    Sera Y et al (2009) Hematopoietic stem cell origin of adipocytes. Exp Hematol 37(9):1108–1120PubMedGoogle Scholar
  49. 49.
    Tomiyama K et al (2008) Characterization of transplanted green fluorescent protein+ bone marrow cells into adipose tissue. Stem Cells 26(2):330–338PubMedGoogle Scholar
  50. 50.
    Koh YJ et al (2007) Bone marrow-derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice. J Clin Invest 117(12):3684–3695PubMedGoogle Scholar
  51. 51.
    Rodeheffer MS, Birsoy K, Friedman JM (2008) Identification of white adipocyte progenitor cells in vivo. Cell 135(2):240–249PubMedGoogle Scholar
  52. 52.
    Zeve D, Tang W, Graff J (2009) Fighting fat with fat: the expanding field of adipose stem cells. Cell Stem Cell 5(5):472–481PubMedGoogle Scholar
  53. 53.
    Yancopoulos GD et al (2000) Vascular-specific growth factors and blood vessel formation. Nature 407(6801):242–248PubMedGoogle Scholar
  54. 54.
    Kolonin MG et al (2012) Alternative origins of stroma in normal organs and disease. Stem Cell Res 8(2):312–323PubMedGoogle Scholar
  55. 55.
    Zhang Y, Bellows CF, Kolonin MG (2010) Adipose tissue-derived progenitor cells and ­cancer. World J Stem Cells 2(5):103–113PubMedGoogle Scholar
  56. 56.
    Grossmann ME et al (2010) Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev 29(4):641–653PubMedGoogle Scholar
  57. 57.
    Zhang J et al (2012) Automated analysis of investigational near-infrared fluorescence ­lymphatic imaging in humans. Biomed Opt Express 3(7):1713–1723PubMedGoogle Scholar
  58. 58.
    Zhang Y et al (2009) White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res 69(12):5259–5266PubMedGoogle Scholar
  59. 59.
    Klopp AH et al (2012) Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res 18(3):771–782PubMedGoogle Scholar
  60. 60.
    Kidd S et al (2012) Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One 7(2):e30563PubMedGoogle Scholar
  61. 61.
    Mancuso P et al (2011) Circulating perivascular progenitors: a target of PDGFR inhibition. Int J Cancer 129(6):1344–1350PubMedGoogle Scholar
  62. 62.
    Bellows CF et al (2011) Circulation of progenitor cells in obese and lean colorectal cancer patients. Cancer Epidemiol Biomarkers Prev 20(11):2461–2468PubMedGoogle Scholar
  63. 63.
    Bellows CF et al (2011) Influence of BMI on level of circulating progenitor cells. Obesity 19(8):1722–1726PubMedGoogle Scholar
  64. 64.
    Bertolini F et al (2012) Adipose tissue cells, lipotransfer and cancer: a challenge for scientists, oncologists and surgeons. Biochim Biophys Acta 1826:209–214PubMedGoogle Scholar
  65. 65.
    Lin G et al (2010) Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate 70(10):1066–1073PubMedGoogle Scholar
  66. 66.
    Martin-Padura I et al (2012) The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression. Cancer Res 72(1):325–334PubMedGoogle Scholar
  67. 67.
    Nieman KM et al (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17(11):1498–1503PubMedGoogle Scholar
  68. 68.
    Dirat B et al (2011) Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71(7):2455–2465PubMedGoogle Scholar
  69. 69.
    Zyromski NJ et al (2009) Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery 146(2):258–263PubMedGoogle Scholar
  70. 70.
    Adams TD et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357(8):753–761PubMedGoogle Scholar
  71. 71.
    Friedman JM (2009) Obesity: causes and control of excess body fat. Nature 459(7245):340–342PubMedGoogle Scholar
  72. 72.
    Bray GA, Greenway FL (2007) Pharmacological treatment of the overweight patient. Pharmacol Rev 59(2):151–184PubMedGoogle Scholar
  73. 73.
    Dolgin E (2012) A history of drugs on the weight list. Nat Med 18(6):843PubMedGoogle Scholar
  74. 74.
    Tharakan G, Tan T, Bloom S (2010) Emerging therapies in the treatment of ‘diabesity’: beyond GLP-1. Trends Pharmacol Sci 32(1):8–15PubMedGoogle Scholar
  75. 75.
    Nawrocki AR, Scherer PE (2005) Keynote review: the adipocyte as a drug discovery target. Drug Discov Today 10(18):1219–1230PubMedGoogle Scholar
  76. 76.
    Cinti S (2009) Transdifferentiation properties of adipocytes in the adipose organ. Am J Physiol Endocrinol Metab 297(5):977–986Google Scholar
  77. 77.
    Wu J et al (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150(2):366–376PubMedGoogle Scholar
  78. 78.
    Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249–257PubMedGoogle Scholar
  79. 79.
    Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438(7070):967–974PubMedGoogle Scholar
  80. 80.
    Hausman GJ, Richardson RL (2004) Adipose tissue angiogenesis. J Anim Sci 82(3):925–934PubMedGoogle Scholar
  81. 81.
    Rupnick MA et al (2002) Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 99(16):10730–10735PubMedGoogle Scholar
  82. 82.
    Christiaens V, Lijnen HR (2010) Angiogenesis and development of adipose tissue. Mol Cell Endocrinol 318(1–2):2–9PubMedGoogle Scholar
  83. 83.
    Brakenhielm E, Cao Y (2008) Angiogenesis in adipose tissue. Methods Mol Biol 456:65–81PubMedGoogle Scholar
  84. 84.
    Gealekman O et al (2008) Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab 295(5):1056–1064Google Scholar
  85. 85.
    Fukumura D et al (2003) Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 93(9):88–97Google Scholar
  86. 86.
    Voros G et al (2005) Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 146(10):4545–4554PubMedGoogle Scholar
  87. 87.
    Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438(7070):932–936PubMedGoogle Scholar
  88. 88.
    Sun K et al (2012) Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci U S A 109(15):5874–5879PubMedGoogle Scholar
  89. 89.
    Hagberg CE et al (2010) Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 464(7290):917–921PubMedGoogle Scholar
  90. 90.
    Lijnen HR et al (2006) Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 55(10):2698–2704PubMedGoogle Scholar
  91. 91.
    Tartare-Deckert S, Chavey C, Monthouel MN, Gautier N, Van Obberghen E (2001) The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. J Biol Chem 276:2231–22237Google Scholar
  92. 92.
    Bradshaw AD et al (2003) SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120(6):949–955PubMedGoogle Scholar
  93. 93.
    Kunduzova O et al (2008) Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB J 22(12):4146–4153PubMedGoogle Scholar
  94. 94.
    Oike Y, Tabata M (2009) Angiopoietin-like proteins—potential therapeutic targets for metabolic syndrome and cardiovascular disease. Circ J 73(12):2192–2197PubMedGoogle Scholar
  95. 95.
    Ledoux S et al (2008) Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 57(12):3247–3257PubMedGoogle Scholar
  96. 96.
    Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395(6704):763–770PubMedGoogle Scholar
  97. 97.
    Sierra-Honigmann MR et al (1998) Biological action of leptin as an angiogenic factor. Science 281(5383):1683–1686PubMedGoogle Scholar
  98. 98.
    Licinio J et al (2004) Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A 101(13):4531–4536PubMedGoogle Scholar
  99. 99.
    Delort L et al (2012) New insights into anticarcinogenic properties of adiponectin: a potential therapeutic approach in breast cancer? Vitam Horm 90:397–417PubMedGoogle Scholar
  100. 100.
    Crandall DL, Hausman GJ, Kral JG (1997) A review of the microcirculation of adipose ­tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4(2):211–232PubMedGoogle Scholar
  101. 101.
    Hoover-Plow J, Ellis J, Yuen L (2002) In vivo plasminogen deficiency reduces fat accumulation. Thromb Haemost 87(6):1011–1019PubMedGoogle Scholar
  102. 102.
    Brakenhielm E et al (2004) Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 94(12):1579–1588PubMedGoogle Scholar
  103. 103.
    Tam J et al (2009) Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells. PLoS One 4(3):e4974PubMedGoogle Scholar
  104. 104.
    Ejaz A et al (2009) Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139(5):919–925PubMedGoogle Scholar
  105. 105.
    Kim MY et al (2010) The anti-angiogenic herbal composition Ob-X inhibits adipose tissue growth in obese mice. Int J Obes (Lond) 34(5):820–830Google Scholar
  106. 106.
    Lijnen HR, Frederix L, Van Hoef B (2010) Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity. Obesity (Silver Spring) 18(12):2241–2246Google Scholar
  107. 107.
    Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8(8):592–603PubMedGoogle Scholar
  108. 108.
    Kappers MH et al (2009) Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects. J Hypertens 27(12):2297–2309PubMedGoogle Scholar
  109. 109.
    Schmidinger M, Bellmunt J (2010) Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma. Cancer Treat Rev 36(5):416–424PubMedGoogle Scholar
  110. 110.
    Yan M et al (2010) Chronic DLL4 blockade induces vascular neoplasms. Nature 463(7282):E6–E7PubMedGoogle Scholar
  111. 111.
    Kim DH, Woods SC, Seeley RJ (2010) Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight. Diabetes 59(4):907–915PubMedGoogle Scholar
  112. 112.
    Woods SC, Seeley RJ (2000) Adiposity signals and the control of energy homeostasis. Nutrition 16(10):894–902PubMedGoogle Scholar
  113. 113.
    Pajvani UB et al (2005) Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 11(7):797–803PubMedGoogle Scholar
  114. 114.
    Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6(4):389–395PubMedGoogle Scholar
  115. 115.
    Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358(19):2039–2049PubMedGoogle Scholar
  116. 116.
    Kolonin MG (2009) Tissue-specific targeting based on markers expressed outside endothelial cells. Adv Genet 67:61–102PubMedGoogle Scholar
  117. 117.
    Kolonin MG et al (2004) Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10(6):625–632PubMedGoogle Scholar
  118. 118.
    Hossen MN et al (2010) Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. J Control Release 147(2):261–268PubMedGoogle Scholar
  119. 119.
    Barnhart KF et al (2011) A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci Transl Med 3(108):108–112Google Scholar
  120. 120.
    Kim DH et al (2012) Rapid and weight-independent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endothelium. Diabetes 61(9):2299–2310PubMedGoogle Scholar
  121. 121.
    Staquicini FI et al (2011) Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proc Natl Acad Sci U S A 108(46):18637–18642PubMedGoogle Scholar
  122. 122.
    Ling Q et al (2004) Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest 113(1):38–48PubMedGoogle Scholar
  123. 123.
    Liu D et al (2012) Mitochondrial dysfunction and adipogenic reduction by prohibitin silencing in 3T3-L1 cells. PLoS One 7(3):e34315PubMedGoogle Scholar
  124. 124.
    Suga H et al (2010) Adipose tissue remodeling under ischemia: death of adipocytes and activation of stem/progenitor cells. Plast Reconstr Surg 126(6):1911–1923PubMedGoogle Scholar
  125. 125.
    Nie J et al (2008) Combinatorial peptides identify α5β1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells. Stem Cells 26(10):2735–2745PubMedGoogle Scholar
  126. 126.
    Rivera LB, Brekken RA (2011) SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-beta1 activity. J Cell Biol 193(7):1305–1319PubMedGoogle Scholar
  127. 127.
    Guzman-Rojas L et al (2012) Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment. Proc Natl Acad Sci U S A 109(5):1637–1642PubMedGoogle Scholar
  128. 128.
    Arap W et al (2002) Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A 99(3):1527–1531PubMedGoogle Scholar
  129. 129.
    Sergeeva A et al (2006) Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 58(15):1622–1654PubMedGoogle Scholar
  130. 130.
    Liu J et al (2012) Selection of aptamers specific for adipose tissue. PLoS One 7(5):e37789PubMedGoogle Scholar
  131. 131.
    Freedland ES (2004) Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab 1(1):12Google Scholar
  132. 132.
    Tran TT, Kahn CR (2010) Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol 6(4):195–213PubMedGoogle Scholar
  133. 133.
    Rutkowski JM, Davis KE, Scherer PE (2009) Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J 276(20):5738–5746PubMedGoogle Scholar
  134. 134.
    Paidisetty S, Blodgett TM (2009) Brown fat: atypical locations and appearances encountered in PET/CT. Am J Roentgenol 193(2):359–366Google Scholar
  135. 135.
    Xue Y et al (2009) Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab 9(1):99–109PubMedGoogle Scholar
  136. 136.
    Reitman ML et al (1999) Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes. Ann N Y Acad Sci 892:289–296PubMedGoogle Scholar
  137. 137.
    Moitra J et al (1998) Life without white fat: a transgenic mouse. Genes Dev 12(20):3168–3181PubMedGoogle Scholar
  138. 138.
    Lijnen HR (2008) Angiogenesis and obesity. Cardiovasc Res 78(2):286–293PubMedGoogle Scholar
  139. 139.
    Crandall DL et al (2006) Modulation of adipose tissue development by pharmacological inhibition of PAI-1. Arterioscler Thromb Vasc Biol 26(10):2209–2215PubMedGoogle Scholar
  140. 140.
    Demeulemeester D, Collen D, Lijnen HR (2005) Effect of matrix metalloproteinase ­inhibition on adipose tissue development. Biochem Biophys Res Commun 329:105–110PubMedGoogle Scholar
  141. 141.
    Bourlier V et al (2005) Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation. J Pharmacol Exp Ther 312(3):1272–1279PubMedGoogle Scholar
  142. 142.
    Shin JH, Shin DW, Noh M (2009) Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes. Biochem Pharmacol 77:1835–1844PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.The University of Texas M.D. Anderson Cancer CenterHoustonUSA
  2. 2.The University of Texas Health Science Center at HoustonHoustonUSA

Personalised recommendations